Comparison of actual hospital costs versus DRG revenues for in-patient treatment of febrile neutropenia during adjuvant anthracycline plus/minus taxane-based chemotherapy for primary breast cancer. [electronic resource]
Producer: 20120404Description: 614-8 p. digitalISSN:- 1423-0240
- Adult
- Aged
- Anthracyclines
- Antineoplastic Agents -- economics
- Antineoplastic Combined Chemotherapy Protocols -- economics
- Breast Neoplasms -- drug therapy
- Bridged-Ring Compounds -- economics
- Comorbidity
- Diagnosis-Related Groups -- economics
- Female
- Fever -- drug therapy
- Germany -- epidemiology
- Health Care Costs -- statistics & numerical data
- Hospitalization -- economics
- Humans
- Income -- statistics & numerical data
- Insurance, Health, Reimbursement -- economics
- Male
- Middle Aged
- Neutropenia -- drug therapy
- Prevalence
- Taxoids -- economics
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.